Stocks and Investing
Stocks and Investing
Fri, September 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sean Dodge Maintained (CDMO) at Buy with Decreased Target to $15 on, Sep 8th, 2023
Sean Dodge of RBC Capital, Maintained "Avid Bioservices, Inc." (CDMO) at Buy with Decreased Target from $17 to $15 on, Sep 8th, 2023.
Sean has made no other calls on CDMO in the last 4 months.
There is 1 other peer that has a rating on CDMO. Out of the 1 peers that are also analyzing CDMO, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Jacob Johnson of "Stephens & Co." Reiterated at Buy and Held Target at $24 on, Thursday, June 22nd, 2023
Contributing Sources